Volpara Health Announces CEO Transition and BOADICEA Integration
Volpara Health, a leader in AI-powered breast health solutions, has announced significant changes in its leadership and product offerings. In a press release, the company stated that Craig Hadfield, currently the Chief Customer and Financial Officer, will assume the role of CEO on April 1. He will succeed Teri Thomas, who has been at the helm since 2022 and played a crucial role in the company's transformation and acquisition by Lunit.
In addition to the leadership transition, Volpara Health has integrated its volumetric breast density assessment into the BOADICEA breast cancer risk model. This integration allows Volpara's density information to be used in the CanRisk web application, enhancing breast cancer risk assessment capabilities for healthcare providers globally. The BOADICEA model, endorsed by international guidelines, is now one of two models incorporating Volpara density, alongside the Tyrer-Cuzick model.
Furthermore, Volpara and Lunit's solutions were prominently featured in 21 independent research abstracts at ECR 2025, underscoring the impact of AI-driven breast health solutions in the radiology community.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 LateralCare brings revenue alai to Microsoft Marketplace Sep 30 NYU Langone Tests AI Tool to Fill Radiology Training Gaps Sep 30 Healthcare Triangle Plans North American Humanoid Nursing Robot Venture Sep 30 Xtalks Plans Webinar on AI Governance in Clinical Development Sep 30 Suvoda Updates Clinical Trial Platform With AI and Unified AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
AbbVie Partners With Valkai on AI Tools for Clinical Development
Suvoda Updates Clinical Trial Platform With AI and Unified Access
Verapath and GenTrust Launch VIRA Wealth Management Platform
Vantora Secures More Than $100 Million From Silversmith
Astrin Names Medical Director as Certitude Breast Expands Nationwide
Daily AI Brief: the AI news that matters, in your inbox.